AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9140679 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg
Number of subjects: 9
Study 9140679 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol 200 mg
Number of subjects: 9
Study 9140679 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 8794554 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual suppression tasks
Number of subjects: 608
Study 8794554 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal suppression tasks
Number of subjects: 608
Study 8794554 — intervention group
Group type: EXPERIMENTAL
Intervention: Single complexity tasks
Number of subjects: 608
Study 8794554 — intervention group
Group type: EXPERIMENTAL
Intervention: Double complexity tasks
Number of subjects: 608
Study 8794554 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed complexity tasks
Number of subjects: 608
Study 8794554 — intervention group
Group type: EXPERIMENTAL
Intervention: Easy difficulty tasks
Number of subjects: 608
Study 8794554 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal difficulty tasks
Number of subjects: 608
Study 8794554 — intervention group
Group type: EXPERIMENTAL
Intervention: Difficult difficulty tasks
Number of subjects: 608
Study 2530027 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% BPAA gel
Number of subjects: 82
Study 2530027 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 1101820 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical polyinosinic acid-polycytidylic acid [poly(I:C)]
Number of subjects: 24
Study 1101820 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 24
Study 31234806 — intervention group
Group type: EXPERIMENTAL
Intervention: FSMS-RUTF
Number of subjects: 389
Study 31234806 — intervention group
Group type: EXPERIMENTAL
Intervention: MSMS-RUTF
Number of subjects: 389
Study 31234806 — intervention group
Group type: COMPARATOR
Intervention: PM-RUTF
Number of subjects: 389
Study 28806436 — intervention group
Group type: EXPERIMENTAL
Intervention: On the Move group exercise program
Number of subjects: 298
Study 28806436 — intervention group
Group type: COMPARATOR
Intervention: Usual care exercise program
Number of subjects: 298
Study 25914263 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced toxicant prototype (RTP) cigarette
Number of subjects: 0
Study 25914263 — intervention group
Group type: COMPARATOR
Intervention: Conventional cigarette
Number of subjects: 0
Study 23480992 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal hemoglobin
Number of subjects: 168
Study 23480992 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal total protein
Number of subjects: 168
Study 21656724 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 160
Study 21656724 — intervention group
Group type: EXPERIMENTAL
Intervention: Operation
Number of subjects: 160
Study 19237443 — intervention group
Group type: EXPERIMENTAL
Intervention: Substantial alcohol exposure in movies and commercials
Number of subjects: 2
Study 19237443 — intervention group
Group type: COMPARATOR
Intervention: No alcohol portrayal
Number of subjects: 2
Study 17078436 — intervention group
Group type: EXPERIMENTAL
Intervention: Point application of medicated cakes
Number of subjects: 60
Study 17078436 — intervention group
Group type: COMPARATOR
Intervention: Ketotifen (control group)
Number of subjects: 60
Study 15198873 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin at a target dose of 14 microg/kg/h
Number of subjects: 17
Study 15198873 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 17
Study 11389251 — intervention group
Group type: EXPERIMENTAL
Intervention: SIPPV plus VG
Number of subjects: 40
Study 11389251 — intervention group
Group type: COMPARATOR
Intervention: SIPPV
Number of subjects: 40
Study 11389251 — intervention group
Group type: EXPERIMENTAL
Intervention: SIMV plus VG
Number of subjects: 40
Study 11389251 — intervention group
Group type: COMPARATOR
Intervention: SIMV
Number of subjects: 40
Study 8988940 — intervention group
Group type: EXPERIMENTAL
Intervention: Total fat intake (38.4% of energy)
Number of subjects: 1000
Study 8988940 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated fatty acids intake (14.2%)
Number of subjects: 1000
Study 8988940 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cholesterol intake (492 mg/d)
Number of subjects: 1000
Study 8988940 — intervention group
Group type: EXPERIMENTAL
Intervention: Special diet adherence
Number of subjects: 1000
Study 8988940 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat intake
Number of subjects: 1000
Study 8988940 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary patterns
Number of subjects: 1000
Study 8988940 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake of total energy and dietary fats
Number of subjects: 1000
Study 8988940 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy product consumption
Number of subjects: 1000
Study 8988940 — intervention group
Group type: EXPERIMENTAL
Intervention: Eggs, sugars, and sweets consumption
Number of subjects: 1000
Study 8988940 — intervention group
Group type: EXPERIMENTAL
Intervention: Cereal foods intake
Number of subjects: 1000
Study 8988940 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary habits based on education level
Number of subjects: 1000
Study 8236129 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance of fatty foods in the month before interview
Number of subjects: 4246
Study 8236129 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased consumption of fatty foods
Number of subjects: 4246
Study 8236129 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual amount of fatty food consumption
Number of subjects: 4246
Study 8236129 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fat reduction
Number of subjects: 4246
Study 8236129 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat diet
Number of subjects: 4246
Study 2904474 — intervention group
Group type: EXPERIMENTAL
Intervention: timolol 0.5%
Number of subjects: 50
Study 2904474 — intervention group
Group type: EXPERIMENTAL
Intervention: betaxolol 0.5%
Number of subjects: 50
Study 2904474 — intervention group
Group type: EXPERIMENTAL
Intervention: carteolol 2%
Number of subjects: 50
Study 2904474 — intervention group
Group type: EXPERIMENTAL
Intervention: pilocarpine 2%
Number of subjects: 50
Study 2904474 — intervention group
Group type: EXPERIMENTAL
Intervention: acetazolamide 750 mg per os
Number of subjects: 50
Study 29650204 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacifier and swaddling
Number of subjects: 30
Study 29650204 — intervention group
Group type: COMPARATOR
Intervention: Control (no pacifier and swaddling)
Number of subjects: 30
Study 28814387 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant (125 mg on day 1, followed by 80 mg on days 2-5)
Number of subjects: 12
Study 28814387 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 25998093 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (5 mg/day)
Number of subjects: 40
Study 25998093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 23073511 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 70
Study 23073511 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 70
Study 21227483 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam 4.8 g daily for 6 months
Number of subjects: 30
Study 21227483 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 6 months
Number of subjects: 30
Study 18494791 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/day TPM
Number of subjects: 77
Study 18494791 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day TPM
Number of subjects: 77
Study 16813180 — intervention group
Group type: EXPERIMENTAL
Intervention: Consciousness‐restoring resuscitation acupuncture (treatment group)
Number of subjects: 60
Study 16813180 — intervention group
Group type: COMPARATOR
Intervention: Chinese medicine (control group)
Number of subjects: 60
Study 12673081 — intervention group
Group type: EXPERIMENTAL
Intervention: CIC 1% cream
Number of subjects: 303
Study 12673081 — intervention group
Group type: COMPARATOR
Intervention: KC 2% foaming gel
Number of subjects: 303
Study 10761807 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery (CABG)
Number of subjects: 769
Study 10761807 — intervention group
Group type: COMPARATOR
Intervention: No CABG or diabetes
Number of subjects: 769
Study 10761807 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical and demographic factors
Number of subjects: 769
Study 8970279 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (14 weeks, 3 times per week using elastic bands)
Number of subjects: 42
Study 8970279 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 42
Study 8970279 — intervention group
Group type: COMPARATOR
Intervention: Resistance training group vs Control group
Number of subjects: 42
Study 1599264 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 mg/mL cyclosporine
Number of subjects: 31
Study 1599264 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/mL cyclosporine
Number of subjects: 31
Study 1599264 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg/mL cyclosporine
Number of subjects: 31
Study 1599264 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 31
Study 6202408 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of bleomycin
Number of subjects: 0
Study 6202408 — intervention group
Group type: COMPARATOR
Intervention: Intermittent bolus injection of bleomycin
Number of subjects: 0
Study 30717805 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy (transfusion of a single RBC unit when Hb ≤ 9 g/dl with a target range for post-transfusion Hb level of 9-10.5 g/dl)
Number of subjects: 2470
Study 30717805 — intervention group
Group type: COMPARATOR
Intervention: Restrictive transfusion strategy (transfusion of a single RBC unit when Hb ≤ 7.5 g/dl with a target range for post-transfusion Hb level of 7.5-9 g/dl)
Number of subjects: 2470
Study 30717805 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy
Number of subjects: 2470
Study 30717805 — intervention group
Group type: COMPARATOR
Intervention: Restrictive transfusion strategy
Number of subjects: 2470
Study 30397236 — intervention group
Group type: EXPERIMENTAL
Intervention: Endorectal cooling balloon (ECB) for regional hypothermia
Number of subjects: 199
Study 30397236 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hypothermia)
Number of subjects: 199
Study 26898919 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid compression during arterial cannulation and aortic declamping
Number of subjects: 40
Study 26898919 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid compression during arterial cannulation
Number of subjects: 40
Study 26898919 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid compression during aortic declamping
Number of subjects: 40
Study 26898919 — intervention group
Group type: COMPARATOR
Intervention: No carotid compression (control group)
Number of subjects: 40
Study 25265986 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% Rumex occidentalis cream
Number of subjects: 45
Study 25265986 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% Hydroquinone cream
Number of subjects: 45
Study 25265986 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 45
Study 23146648 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Adjusting File (SAF; ReDent Nova)
Number of subjects: 72
Study 23146648 — intervention group
Group type: COMPARATOR
Intervention: Typhoon (Typhoon rotary files with Controlled Memory Wire; DS Dental)
Number of subjects: 72
Study 23146648 — intervention group
Group type: COMPARATOR
Intervention: Vortex (ProFile Vortex rotary files with M-Wire NiTi; Dentsply Tulsa Dental Specialties)
Number of subjects: 72
Study 20380479 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen syrup 0.5 mg/kg
Number of subjects: 0
Study 20380479 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen suspension 5 mg/kg
Number of subjects: 0
Study 20380479 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol suspension 15 mg/kg
Number of subjects: 0
Study 18852422 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual impairment
Number of subjects: 14037
Study 18852422 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual impairment (adjusted for confounding factors)
Number of subjects: 14037
Study 16115978 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (Mg) 2.48 mmol
Number of subjects: 100
Study 16115978 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg
Number of subjects: 100
Study 16115978 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.2 mg/kg
Number of subjects: 100
Study 16115978 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 100
Study 12353197 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir 250 mg (9.4‐13.3 mg/kg) twice daily
Number of subjects: 28
Study 12353197 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg (13.9‐27.0 mg/kg) twice daily
Number of subjects: 28
Study 12353197 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg (13.2‐21.7 mg/kg) 3 times a day
Number of subjects: 28
Study 12353197 — intervention group
Group type: COMPARATOR
Intervention: Intravenous acyclovir (historical data)
Number of subjects: 28
Study 10079655 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care education program
Number of subjects: 2
Study 10079655 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group method
Number of subjects: 2
Study 10079655 — intervention group
Group type: EXPERIMENTAL
Intervention: Small group learning modules
Number of subjects: 2
Study 7497073 — intervention group
Group type: EXPERIMENTAL
Intervention: Probabilistic reasoning in self‐threatening anxiety states
Number of subjects: 66
Study 7497073 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple yes‐or‐no decisions in physically threatening anxiety states
Number of subjects: 66
Study 7497073 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐threatening anxiety states with probabilistic judgments
Number of subjects: 66
Study 7497073 — intervention group
Group type: EXPERIMENTAL
Intervention: Physically threatening anxiety states with simple yes‐or‐no judgments
Number of subjects: 66
Study 7497073 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing styles alone
Number of subjects: 66
Study 2153491 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine infusion
Number of subjects: 5
Study 2153491 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact hypoxic ventilatory drive
Number of subjects: 5
Study 2153491 — intervention group
Group type: EXPERIMENTAL
Intervention: Attenuated chemoreflexes
Number of subjects: 5
Study 2153491 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia
Number of subjects: 5
Study 7224346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 7224346 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral theophylline
Number of subjects: 38
Study 31800752 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical Therapy (ST)
Number of subjects: 16
Study 31800752 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical Therapy (NST)
Number of subjects: 16
Study 28822166 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Da Chaihu decoction
Number of subjects: 126
Study 28822166 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine besylate tablets
Number of subjects: 126
Study 28822166 — intervention group
Group type: COMPARATOR
Intervention: Flupentixol and melitracen tablets
Number of subjects: 126
Study 26432182 — intervention group
Group type: EXPERIMENTAL
Intervention: 225 mg TEV-48125
Number of subjects: 297
Study 26432182 — intervention group
Group type: EXPERIMENTAL
Intervention: 675 mg TEV-48125
Number of subjects: 297
Study 26432182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297
Study 23582671 — intervention group
Group type: EXPERIMENTAL
Intervention: Early assisted discharge (discharge at day 4 with home care nurse visits until day 7)
Number of subjects: 139
Study 23582671 — intervention group
Group type: COMPARATOR
Intervention: Usual hospital care (discharged at day 7)
Number of subjects: 139
Study 23582671 — intervention group
Group type: EXPERIMENTAL
Intervention: Early assisted discharge
Number of subjects: 139
Study 23582671 — intervention group
Group type: COMPARATOR
Intervention: Usual hospital care
Number of subjects: 139
Study 21672926 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant LH (rLH) added to controlled ovarian hyperstimulation (COH)
Number of subjects: 206
Study 21672926 — intervention group
Group type: EXPERIMENTAL
Intervention: One extra daily injection of rLH
Number of subjects: 206
Study 19320829 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate
Number of subjects: 20
Study 19320829 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 19320829 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyethyl starch (HES) 130/0.4
Number of subjects: 20
Study 17623467 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-378806 (100 to 1600 mg single oral dose)
Number of subjects: 0
Study 17623467 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-378806 (100 to 1200 mg)
Number of subjects: 0
Study 17623467 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-378806 (1600 mg)
Number of subjects: 0
Study 17623467 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-378806 with food
Number of subjects: 0
Study 17623467 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-378806 as a solution formulation
Number of subjects: 0
Study 17623467 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-378806
Number of subjects: 0
Study 15530201 — intervention group
Group type: EXPERIMENTAL
Intervention: Typing skills intervention group
Number of subjects: 311
Study 15530201 — intervention group
Group type: COMPARATOR
Intervention: Daily typed journal group
Number of subjects: 311
Study 11170143 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathological stage
Number of subjects: 218
Study 11170143 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor volume
Number of subjects: 218
Study 11170143 — intervention group
Group type: EXPERIMENTAL
Intervention: Margin status
Number of subjects: 218
Study 11170143 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportion of poorly differentiated cancer
Number of subjects: 218
Study 9823790 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional coronary atherectomy (DCA)
Number of subjects: 0
Study 9823790 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational atherectomy
Number of subjects: 0
Study 9823790 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary stents
Number of subjects: 0
Study 7827218 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic disorder patients
Number of subjects: 50
Study 7827218 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 50
Study 3415803 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertatolol (5 mg)
Number of subjects: 8
Study 3415803 — intervention group
Group type: COMPARATOR
Intervention: Nadolol (80 mg)
Number of subjects: 8
Study 31421024 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-and-extend protocol with moderate extensions (T&Em)
Number of subjects: 52
Study 31421024 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-and-extend protocol with rapid extensions (T&Er)
Number of subjects: 52
Study 29252047 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BR; 140 ml/day, ∼800 mg/day nitrate)
Number of subjects: 14
Study 29252047 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PLA)
Number of subjects: 14
Study 29252047 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BR)
Number of subjects: 14
Study 26573267 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of CPRmeter® device
Number of subjects: 88
Study 26573267 — intervention group
Group type: COMPARATOR
Intervention: No use of CPRmeter® device (Control Group A)
Number of subjects: 88
Study 24636143 — intervention group
Group type: EXPERIMENTAL
Intervention: Group manual‐course (GMC)
Number of subjects: 40
Study 24636143 — intervention group
Group type: COMPARATOR
Intervention: Group manual‐orientations (GMO)
Number of subjects: 40
Study 23413606 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel pharmacological options targeting androgen signaling
Number of subjects: 0
Study 23413606 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel radioisotope therapies
Number of subjects: 0
Study 23413606 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytotoxic agents
Number of subjects: 0
Study 23413606 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic interventions targeting new molecular pathways
Number of subjects: 0
Study 21353117 — intervention group
Group type: EXPERIMENTAL
Intervention: New generic formulation of bicalutamide 50-mg tablets (test)
Number of subjects: 32
Study 21353117 — intervention group
Group type: COMPARATOR
Intervention: Currently marketed formulation of bicalutamide 50-mg tablets (reference)
Number of subjects: 32
Study 21353117 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 32
Study 18083505 — intervention group
Group type: EXPERIMENTAL
Intervention: Lycopus europaeus
Number of subjects: 0
Study 18083505 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 17309908 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin 2 mg/kg, rifampicin 600 mg, vancomycin 15 mg/kg (with three further doses of 7.5 mg/kg at 12-hour intervals)
Number of subjects: 186
Study 17309908 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime 1.5 g at induction and three further doses of 750 mg at 8-hour intervals
Number of subjects: 186
Study 17309908 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin, rifampicin, vancomycin
Number of subjects: 186
Study 12925049 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of ANP (0.25 microg/kg/min in 0.9% NaCl) after 3 weeks' pre‐treatment with placebo
Number of subjects: 7
Study 12925049 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion of vehicle (0.9% NaCl only) after 3 weeks' pre‐treatment with placebo
Number of subjects: 7